Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

November 6, 2024

Study Completion Date

November 6, 2024

Conditions
Rheumatoid ArthritisCardiovascular DiseasesHyperlipidemias
Interventions
BEHAVIORAL

Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis

This intervention will help people with RA get tested for hyperlipidemia so that they can later discuss with their physician how to better treat their increased risk for cardiovascular disease.

BEHAVIORAL

Standard of care

Participants in this group will not receive peer coaches calls. They will receive additional educational materials about CVD risk and the regular care provided by their doctors.

Trial Locations (1)

10021

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT04488497 - Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis: | Biotech Hunter | Biotech Hunter